Vivanza Biosciences Ltd
NSE: BSE: 530057
₹2.07
(-1.43%)
Wed, 22 Apr 2026, 06:09 pm
Market Cap84M
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KVivanza Biosciences Cashflow
| Particulars | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -98.42K | -74.00K | -26.00K | -121.00K | -140.00K |
| Accumulated depreciation, total | -9.93M | -9.93M | -6.70M | — | — | — | — | -2.03M | -1.85M | -1.85M | -1.85M | -1.95M | -2.03M | -2.05M | -2.17M | -2.31M |
| Cash from operating activities | 0 | 0 | -7.52M | -5.71M | -366.32K | -447.84K | -464.55K | -21.11M | -4.39M | 4.42M | 25.43M | -32.32M | -5.35M | -2.00M | 3.82M | -35.03M |
| Funds from operations | -10.00K | -10.00K | -7.75M | -16.23M | -534.68K | -525.91K | -603.32K | -2.66M | 2.41M | -4.41M | -2.06M | 848.21K | 3.40M | 6.01M | 5.58M | -6.59M |
| Net income (cash flow) | -10.00K | -10.00K | -2.02M | -15.99M | -534.68K | -525.91K | -603.32K | -3.11M | 2.05M | -4.41M | -2.06M | 753.35K | 3.33M | 5.98M | 5.47M | -6.74M |
| Depreciation & amortization (cash flow) | — | — | — | — | — | — | 0 | — | — | — | — | 98.42K | 74.00K | 26.00K | 121.00K | 140.00K |
| Depreciation/depletion | — | — | — | — | — | — | 0 | — | — | — | — | 98.42K | — | — | — | — |
| Amortization | — | — | — | — | — | — | 0 | — | — | — | — | — | — | — | — | — |
| Deferred taxes (cash flow) | — | — | — | — | — | — | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 0 | 0 | -5.74M | -238.71K | 0 | 0 | 0 | 452.31K | 71.17K | 0 | 0 | -485.08K | -11.00K | -1.18M | -1.49M | -70.00K |
| Changes in working capital | 10.00K | 10.00K | 227.98K | 10.52M | 168.36K | 78.06K | 138.76K | -18.45M | -6.79M | 8.83M | 27.49M | -33.17M | -8.75M | -8.02M | -1.76M | -28.45M |
| Cash from investing activities | 0 | 0 | 13.35M | 4.97M | 0 | 0 | 0 | 19.03M | 0 | 0 | 0 | -211.20K | 0 | 0 | -375.00K | -79.00K |
| Capital expenditures | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -211.20K | 0 | 0 | -375.00K | -79.00K |
| Capital expenditures - fixed assets | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -211.20K | — | — | -375.00K | -79.00K |
| Capital expenditures - other assets | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 |
| Cash from financing activities | 0 | 0 | -4.86M | -142.99K | 300.00K | 930.00K | 250.00K | 4.37M | -1.99M | -4.76M | -23.20M | 29.37M | 5.25M | 2.86M | -3.18M | 34.61M |
| Free cash flow | — | — | — | -5.71M | -366.32K | -447.84K | -464.55K | -21.11M | -4.39M | 4.42M | 25.43M | -32.53M | — | — | 3.44M | -35.11M |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800